ToplineKimberly-Clark will acquire Kenvue in a deal valued at nearly $49 billion, both companies announced Monday, combining the maker of Huggies diapers and Kleenex with the owner of Tylenol, which has faced pressure since President Donald Trump claimed without conclusive evidence the drug is a potential cause of autism. President Donald Trump has claimed Kenvue’s pain reliever is a potential cause of autism, despite clear evidence.AFP via Getty Images ...